ASPI: a public-private partnership to develop treatments for autism

Seth Ness, Gahan Pandina, Shyla Jagannatha, Kyle Wathen, Abigail Bangerter, Nikolay V Manyakov, Robert L Hendren, Bennett L. Leventhal, Declan Murphy, Geraldine Dawson, Wayne C. Drevets, Husseini Manji

Research output: Contribution to journalComment/debatepeer-review

5 Citations (Scopus)

Abstract

Numerous potential therapeutic targets are being investigated in autism spectrum disorder (ASD). Here, we discuss a platform trial approach for designing proof-of-concept (POC) clinical studies of ASD — via the Autism Spectrum POC Initiative (ASPI) — that can be conducted through a public–private partnership with the aim of finding effective treatments in the most expeditious manner.

Original languageEnglish
Pages (from-to)219-220
Number of pages2
JournalNature Reviews Drug Discovery
Volume19
Issue number4
DOIs
Publication statusPublished - 1 Apr 2020

Fingerprint

Dive into the research topics of 'ASPI: a public-private partnership to develop treatments for autism'. Together they form a unique fingerprint.

Cite this